Terms and Conditions

THIS AGREEMENT (this “Agreement”) is entered into as of the date of the Order (the “Effective Date”), by and between Embryll Life Sciences, Inc. (“Embryll”), and the customer listed on the Order (“Purchaser”), collectively referred to herein as the “parties”, or severally as the “party”.

These terms and conditions shall govern all terms and conditions of purchase and sale of Embryll Materials and shall constitute a legally-binding contract between the parties. Any additional terms or conditions stated in any purchase order (including but not limited to the “reverse side” or boilerplate terms of any purchase order), invoices or other directions or instructions shall not be binding upon the parties unless separately agreed to by the receiving Party in writing.

1. Definitions

Unless otherwise defined herein, all initially capitalized terms used in this Agreement shall have the following meanings:

1.1 “Deliverable(s)” means any material, data, analysis and documentation required to be delivered to Purchaser as described in this Agreement.

1.2 “Material” means Embryll product specified in Order.

1.3 “Order” means an order submitted by Purchaser for the purchase of Material.

2. Orders

2.1 Orders. Embryll shall use reasonable business efforts to notify Purchaser if the materials or services requested in a purchase order cannot be fulfilled; otherwise Embryll will notify Purchaser of the estimated delivery date for such materials and/or services.

Prior to Embryll’s notification to Purchaser of acknowledgment of an order, Purchaser may cancel the outstanding order by providing Embryll with written notice of cancellation. Once Embryll has acknowledged a purchase order, such purchase order shall become non-cancellable without Embryll’s prior written consent.

2.2 Delivery. Embryll will use reasonable business efforts to fulfill each Order within a reasonable period of time. All ship dates specified by Embryll are Embryll’s best approximation of the anticipated ship date and shall not be deemed to represent a fixed or guaranteed ship date. Embryll reserves the right to ship all of the Materials covered by any Order at one time or in separate parts or lots from time to time.

All Materials shall be shipped to Purchaser EXW (Embryll Facility) INCOTERMS 2020, unless otherwise agreed in a writing signed by Embryll. All risk of loss, damage, or destruction of the Products shall pass to Purchaser on delivery of Products by Embryll to the carrier at Embryll’s facility. Embryll will select the mode of shipment and the carrier. Embryll will be responsible for pre-carriage costs and arrangements up to the point that the goods are delivered to the carrier, and Purchaser will be responsible for and pay all packing, shipping, freight, and insurance charges and export costs thereafter.

2.3 Taxes. Purchaser shall be responsible for and shall promptly pay all sales, use, value added, withholding, and other taxes and duties, if any, levied or imposed on either party as a result of the transactions contemplated by this Agreement and Embryll will be promptly reimbursed for any and all taxes or duties (excluding income taxes) that Embryll may be required to pay in connection with this Agreement.

2.4 Changes. Any changes to the scope of the Order shall be set forth in a written amendment executed by an authorized representative of the Purchaser and Embryll.

2.5 Acceptance. Purchaser shall immediately accept or reject the Deliverables upon delivery from Embryll, and provide a prompt written statement of nonconformities to be corrected by Embryll prior to Purchaser’s acceptance of the Deliverables; provided, however, that if Purchaser fails to provide such written notice of non-conformance within ten (10) days of Purchaser’s receipt of such Deliverables, the Deliverables will be deemed to have been accepted by Purchaser.

3. Compensation

3.1 General. All payments to Embryll shall be made in U.S. Dollars, free of currency controls or other restrictions, and are exclusive of all sales, use, value added, withholding, and other taxes and duties. Purchaser shall be responsible for and shall promptly pay all sales, use, value added, withholding, and other taxes and duties, if any, levied or imposed on either Party as a result of the transactions contemplated by this Agreement, and Embryll will be promptly reimbursed for any and all taxes or duties (excluding income taxes) that Embryll may be required to pay in connection with this Agreement.

3.2 Payment Terms. Company shall pay all invoices within thirty (30) days of the date of the invoice. Should Purchaser fail to make any undisputed payments to Embryll within such thirty (30) days, interest will accrue on such overdue amount at the lesser of (a) eighteen percent (18%) per annum, or (b) the maximum rate permitted by law.

4. Warranties

4.1 Embryll warrants that (a) cells included in the Embryll Material shall be viable upon initiation of culture for a period of thirty (30) days after shipment thereof from Embryll and (b) any Embryll Material other than cells shall meet the specifications on the applicable Embryll Material product information sheet, certificate of analysis, and/or catalog description until the expiration date on the applicable Embryll Material’s product label (such thirty (30) day period, or period until the expiration date, referred to herein as the “Warranty Period”). Purchaser’s exclusive remedy, and Embryll’s sole liability, for breach of the warranties set forth in this paragraph is for Embryll to, at Embryll’s sole option, either (i) refund the fee paid to Embryll for such Embryll Material (exclusive of shipping and handling charges), or (ii) replace the Embryll Material. The warranties set forth in this paragraph apply only if Purchaser handles and stores the Embryll Material as described in the applicable Embryll Material product information sheet. To obtain the exclusive remedy, Purchaser must report the lack of viability or non-conformation to specifications to Embryll’s Technical Service Department within the applicable Warranty Period. Any expiration date specified on the Embryll Material shipment documentation states the expected remaining useful life, but does not constitute a warranty or extend any applicable Warranty Period.


5. Publicity

5.1 Except as required to comply with applicable laws, Purchaser shall not mention or otherwise use the name, insignia, symbol, trademark, trade name, or logotype of Embryll (or any abbreviation or adaptation thereof) in any publication, press release, promotional material, or other form of publicity regarding the provision of Services without the prior written approval of Embryll in each instance.

6. Indemnification

Purchaser agrees to indemnify, defend, and hold harmless Embryll, its affiliates, and their respective directors, officers, employees, and personnel from and against any third party claims, actions or proceedings (“Claims”) arising out of, attributable to, or resulting from any Purchaser (a) use, handling, or storage of the Deliverables and any materials, products, or services based upon or relating to the Deliverables, including but not limited to any claim that any such use, handling or storage infringes upon any third party intellectual property rights; (b) negligent or reckless acts or omissions, or willful misconduct; (c) breach of any covenant, representation or warranty of Purchaser under this Agreement; or (d) failure to comply with applicable laws. Embryll shall provide the Purchaser prompt notice of any such Claim, including a copy thereof, served upon it, and shall cooperate fully with the Purchaser and its legal representatives in the investigation of any such Claim, at the Purchaser’s expense. The Purchaser shall have the right to exercise sole control over the defense and settlement of any such Claim, including the sole right to select defense counsel and to direct the defense or settlement of any such Claim; provided that the Purchaser shall not enter into any settlement that admit fault or liability on Embryll’s part without the prior written consent of Embryll. Embryll shall have the right to select and to obtain representation by separate legal counsel. If Embryll exercises such right, all costs and expenses incurred by Embryll for such separate legal counsel shall be borne by Embryll. The Purchaser shall be relieved of any indemnification obligation hereunder if Embryll either (a) compromises or settles any Claim without the Purchaser’s prior written approval; or (b) makes any admission or takes any other action with respect to any such Claim that is prejudicial to the defense of such Claim, without the Purchaser’s prior written approval.

7. Limitation of Liability

EXCEPT FOR LIABILITY ARISING UNDER THE PURCHASER’s INDEMNITY OBLIGATIONS FOR CLAIMS ASSERTED BY THIRD PARTIES, AND TO THE EXTENT NOT PROHIBITED BY LAW, IN NO EVENT SHALL EITHER PARTY HEREUNDER BE LIABLE TO THE OTHER PARTY HEREUNDER FOR SPECIAL, INCIDENTAL, CONSEQUENTIAL OR INDIRECT DAMAGES ARISING FROM OR IN RELATION TO THIS AGREEMENT, THE PURCHASED MATERIAL OR SERVICES (WHETHER IN CONTRACT, TORT, NEGLIGENCE, STRICT LIABILITY, BY STATUTE OR OTHERWISE). THIS LIMITATION SHALL APPLY EVEN IF SUCH PARTY HAS BEEN ADVISED OR IS AWARE OF THE POSSIBILITY OF SUCH DAMAGES. EMBRYLL’s MAXIMUM AGGREGATE LIABILITY TO PURCHASER HEREUNDER FOR ANY CLAIM RELATED TO, OR IN CONNECTION WITH, THIS AGREEMENT OR MATERIALS (WHETHER IN CONTRACT, TORT, NEGLIGENCE, STRICT LIABILITY, BY STATUTE OR OTHERWISE) SHALL BE LIMITED TO AN AMOUNT EQUAL TO THE TOTAL PAYMENTS BY PURCHASER TO EMBRYLL UNDER THIS AGREEMENT. This remedy is intended to be the sole and exclusive remedy of Purchaser under this Agreement. Should this sole and exclusive remedy fail of its essential purpose, however, Embryll will return the purchase price to Purchaser minus the reasonable value of the Purchaser’s use of the purchased materials or services. The parties also agree that, regardless of the failure of the sole and exclusive remedy, Embryll will not be liable for any consequential damages of whatsoever kind or nature. The parties intend the exclusion of consequential damages as an independent agreement apart from the sole and exclusive remedy herein.

8. Miscellaneous

8.1 Independent Contractors. The parties are independent contractors, and neither party’s employees nor agents shall be considered to be an employee, partner, joint venturer, or agent of the other party, nor entitled to any of the benefits that each party provides to its own employees. Neither party shall represent, suggest, or otherwise imply to any person that such person or entity is an employee or agent of the other party or has the authority to contractually bind the other party.

8.2 Force Majeure. In the event Embryll is delayed or hindered in or prevented from the performance of any act required hereunder by reasons of strike, lockouts, labor troubles, inability to procure materials, failure of power or restrictive governmental or judicial orders or decrees, riots, insurrection, war, acts or God, acts of terrorism, inclement weather or other similar reasons or cause beyond its control (“Force Majeure Event”), then performance of such act shall be excused for the period of such delay, provided that Embryll provides prompt written notice of such event, and uses reasonable efforts to avoid or remove the cause of such Force Majeure Event, and shall resume performance of its obligations as soon as practicable thereafter.

8.3 Integration. This Agreement constitutes the entire agreement among the parties with respect to the subject matter herein and supersedes all prior and contemporaneous agreements, whether written or oral, of the parties hereto, relating to the subject matter herein. For the avoidance of doubt, any terms and conditions or other notations provided by Purchaser on a Purchaser Sales Order form or any other form or order, whether inconsistent with or supplemental to this Agreement, are hereby rejected and shall be void and of no force or effect.

8.4 Assignment. Neither party may assign or otherwise transfer this Agreement, or any rights or obligations hereunder without the prior written consent of the other party, which consent shall not be unreasonably withheld, and any attempted sale, pledge, assignment, sublicense or other transfer in violation thereof shall be void and of no force or effect, provided, however, either party may, without such consent, assign this Agreement and its rights and obligations hereunder in connection with the transfer or sale of all or substantially of its business, or in the event of its merger, consolidation, change in control or similar action. This Agreement shall be binding upon the parties, their legal representatives, and permitted successors and assigns.

8.5 Disputes. All disputes, controversies or claims arising under or related in any manner to this Agreement (“Disputes”) shall be resolved in accordance with this Section 8.5, and any issue concerning the extent to which any Dispute is subject to arbitration, or any dispute concerning the applicability, interpretation, or enforceability of these procedures, including any contention that all or part of these procedures are invalid or unenforceable, shall be governed by the Federal Arbitration Act (as the same may be amended or supplemented from time to time) and resolved by the arbitral tribunal constituted hereunder. Excluding any actual or threatened breaches of confidentiality or intellectual property rights for which the parties may obtain injunctive or other equitable relief in a court of law as provided in this Section 8.5, these arbitration procedures shall be the sole and exclusive process for the resolution of any such Dispute; provided however, if a claim seeks both equitable relief and other relief, the portion of the claim that seeks relief other than equitable relief shall be dismissed without prejudice so as to be resolved by binding arbitration as provided below.

Disputes shall be governed by and construed in accordance with the substantive laws of the State of Delaware, without regard to its conflicts of law rules, and shall be resolved and decided pursuant to the rules of arbitration by American Arbitration Association (“AAA”) and conducted in Wilmington, Delaware before a panel of three arbitrators (one arbitrator chosen by each of the parties and the third arbitrator chosen by the first two, unless the parties agree otherwise in writing), at least two (2) of whom shall have a minimum of five (5) years of experience in providing services in the biotechnology or pharmaceutical fields; provided however no potential arbitrator shall be appointed unless he or she has agreed in writing to abide and be bound by these terms and procedure. In the event of any conflict between the AAA rules and any provisions of this Agreement, the terms of this Agreement shall govern.

The parties acknowledge that time is of the essence in the initiation and completion of the arbitration, and that unless the arbitral tribunal expressly orders otherwise, the Dispute should be submitted to the tribunal for decision within nine (9) months after the commencement of the arbitration, and its final award shall be rendered within ninety (90) days thereafter. The parties agree that notifications of any proceedings, reports, communications or any other document in connection with a Dispute shall be in English and sent as set forth in Section 8.6 of this Agreement. The arbitration panel may only award damages as provided for under the terms of the Agreement. The arbitrators shall have the authority to allocate between the parties, the costs of arbitration, including but not limited to reasonable attorneys’ fees, in such equitable manner as they determine. The parties irrevocably agree that the judgment of the arbitration panel shall be final and binding on the parties and their permitted successors and assigns, and shall be enforceable in any court of competent jurisdiction.

The parties agree that all legal actions or proceedings seeking injunctive or equitable relief, as well as any proceeding to enforce an arbitral award hereunder, shall be brought exclusively in the State and Federal Courts of the State of Delaware, and the parties hereby irrevocably consent and submit to such jurisdiction and venue.

8.6 Compliance with Laws. Purchaser shall comply with all applicable laws, regulations and ordinances, including but not limited to those pertaining to the following: export control, transportation of organisms and vectors, and introduction or use of chemical substances. Purchaser shall maintain in effect all required licenses, permissions, authorizations, consents, and permits. Purchaser shall comply with all applicable export and import laws in its purchase of Material hereunder and assumes all responsibility for all shipments governed by such laws. Embryll may terminate the Agreement or suspend delivery if any governmental authority imposes restrictions on the Material.

8.7 Notices. Any notices provided for or required under this Agreement shall be in writing and delivered to the parties at the postal addresses set forth in the Embryll Sales Order, by (a) first class certified mail, return receipt requested, or (b) a nationally-recognized overnight courier service,

8.8 Severability; Waiver; Amendments; Counterparts. If any provision of this Agreement is for any reason found to be unenforceable or invalid, the remainder of this Agreement shall continue in full force and effect as if such invalid or unenforceable provision had not been included herein. Failure to enforce any rights under this Agreement, regardless of the length of time such failure continues, shall not constitute a waiver of those or any other rights or any future breaches, unless in a writing signed by authorized representatives of the non-breaching party and then only to the extent expressly set forth in such writing. This Agreement may be amended only by a writing signed by any authorized representative of Purchaser and Embryll. This Agreement may be executed in counterparts, and transmitted by electronic means, including through portable document format or via facsimile, each of which shall be deemed an original, but all of which together shall constitute one and the same agreement.

Last Updated Jan 1, 2022